You are here: Home » News-CM » Companies » News
Business Standard

Alembic Pharmaceutical inaugurates oncology manufacturing facility

Capital Market 

At Panelav, Halol

Alembic Pharmaceutical has inaugurated its state-of-the-art Anti-Cancer Manufacturing Facility at Panelav, Halol. The Rs 300 crore oncology manufacturing facility has an initial manufacturing capacity of 60 million tablets/ capsules and approximately 20 million vials of liquid injectable and lyophilised concentrates.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)